Screener
West Pharmaceutical Services WST EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Equity in net income of affiliated companies | (6.1) | (5.0) | (9.5) | (8.4) |
| Net income | $154.0 | $131.8 | $292.8 | $221.6 |
| Net income per share: | ||||
| Basic | $2.17 | $1.82 | $4.10 | $3.06 |
| Diluted | $2.15 | $1.82 | $4.07 | $3.05 |
| Weighted average shares outstanding: | ||||
| Basic | 70.8 | 72.2 | 71.4 | 72.3 |
| Diluted | 71.3 | 72.5 | 71.9 | 72.8 |
Item 1. FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is West Pharmaceutical Services's EPS (basic)?
- West Pharmaceutical Services (WST) reported EPS (basic) of $2.17 in Q2 2026.
- How has West Pharmaceutical Services's EPS (basic) changed year-over-year?
- West Pharmaceutical Services's EPS (basic) increased by 19.2% year-over-year, from $1.82 to $2.17.
- What is the long-term trend for West Pharmaceutical Services's EPS (basic)?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's EPS (basic) has grown at a -6.4% compound annual growth rate (CAGR), from $8.88 to $6.83.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about West Pharmaceutical Services's eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude